LONDON, April 4, 2018 /PRNewswire/ --
Stem Cell Therapies, Tissue Engineered Products, Gene Therapies
The Global Translational Regenerative Medicine market is estimated to grow at a CAGR of 22.1% in the first half of the forecast period. Stem cell therapies accounted for the majority of the revenue in the market with an estimated market share of 56.0% in 2017.
How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new report you find 306-page report you will receive 109 tables and 67 figures - all unavailable elsewhere.
The 306-page report provides clear detailed insight into the Global Translational Regenerative Medicine market. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand new report today you stay better informed and ready to act.
• Global Translational Regenerative Medicine submarket forecasts from 2018-2028 covering:
• Stem Cell Therapies
• Tissue Engineered Products
• Gene Therapies
This study discusses the late-state clinical trials and pipeline as well as market drivers and restraints of each submarket.
• Translational Regenerative Medicine regional market forecasts from 2018-2028, covering:
• United States
• Rest of the World
• Forecasts from 2018-2028 of the leading products in the Global Translational Regenerative Medicine market:
• Osteocel Plus
• Trinity ELITE
• TEMCELL /Prochymal
• Glybera (alipogene tiparvovec)
• IMLYGIC (talimogene laherparepvec)
• Assessment of the leading companies in the Global Translational Regenerative Medicine market:
• Alphatec Spine
• Avita Medical
• Ocata Therapeutics
• Vericel Corporation
• Information on current developments, current advancements and current key approvals in the field of translational regenerative medicine market.
• SWOT and Porter's Five Force analysis of the translational regenerative medicine market
Visiongain's study is intended for anyone requiring commercial analyses for the Translational Regenerative Medicine Market and leading companies. You find data, trends and predictions.
Buy our report today Global Translational Regenerative Medicine Market Prospects 2018-2028: Stem Cell Therapies, Tissue Engineered Products, Gene Therapies.
To request a report overview of this report please email Sara Peerun at firstname.lastname@example.org or call Tel: +44-(0)-20-7336-6100
List of Companies Mentioned in the Report
Abeona Therapeutics Inc.
Advanced Tissue Sciences
Alliqua BioMedical, Inc.
BioMed Realty Trust, Inc
Bluebird bio, Inc.
BrainStorm Cell Therapeutics
California Stem Cell Inc
Cellular Dynamics International, Inc.
Cook Biotech Inc
Cytori Therapeutics, Inc.
DePuy Mitek (Johnson & Johnson)
Dimension Therapeutics, Inc.
Gamida Cell Ltd
Genzyme Corporation (Sanofi)
Homology Medicines, Inc.
Human Stem Cell Institute
Janssen Biotech Inc
Japan Tissue Engineering Co
Johnson & Johnson
Kinetic Concept Inc
Lincoln Park Capital
Lonza Houston, Inc.
MiMedx Group, Inc.
Nippon Zoki Pharmaceuticals
Orphan Biovitrum AB (Sobi)
Promethera Biosciences SA
Reliance Life Sciences
Shanghai Sunway Biotech
Shenzhen Sibiono GeneTech
Singapore General Hospital
Smith & Nephewbv
TCA Cellular Therapy
U.S. Stem Cell Inc.
WKD Holding Oy
To see a report overview please email Sara Peerun on email@example.com